GaBI Journal-Generics and Biosimilars Initiative Journal
Pro Pharma Communications International · Belgium
Metrics
- Impact factor
- 0.3+0.1 Clarivate JCR
- WoS quartile
- Q4 Clarivate JCR, best category
- SJR
- 0.224Q1 SCImago
- h-index
- 16
- CAS tier
- Tier 4 Chinese Academy of Sciences
- Citations per paper
- 0.36 last 2 years
- Articles per year
- 1
- Self-citation
- 0%
- Fee (APC), est.
- $2,408 estimated, check the journal
About this journal
- ISSN
- 2033-6403 (print) · 2033-6772 (online)
- Publisher
- Pro Pharma Communications International
- Country
- Belgium · Western Europe
- Indexed in
- ESCI
- Access
- Subscription · 0% gold OA
- Original research
- 0%
- Subject areas
- Health Professions, Medicine
- Categories
- Pharmacology & Pharmacy
- Common topics
- Medicine, Business, Biology, Internal medicine, Genetics
Similar journals
- Q4WoS
Acta Radiologica
Impact factor 1.2h-index 66SJR 0.41 - Q4WoS
Radiation Protection Dosimetry
Impact factor 0.8h-index 64SJR 0.23 - Q4SJR
Annals of the ICRP
h-index 61SJR 0.18 - Q4WoS
Journal of the American Podiatric Medical Association
Impact factor 0.7h-index 52SJR 0.23 - Q4WoS
JOURNAL OF PHARMACY PRACTICE
Impact factor 1h-index 43SJR 0.41 - Q4WoS
Pharmacy Practice-Granada
Impact factor 0.7h-index 42SJR 0.30
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals